YAŞAR, Ü. Et Al. 2011. Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.109, no.2 , 73-77.

YAŞAR, Ü., SAİN GÜVEN, G., Yardimci, Y., KILIÇARSLAN, A., BABAOĞLU, M. Ö., & BOZKURT, A., (2011). Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.109, no.2, 73-77.

YAŞAR, ÜMİT Et Al. "Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients," BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.109, no.2, 73-77, 2011

YAŞAR, ÜMİT Et Al. "Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.109, no.2, pp.73-77, 2011

YAŞAR, Ü. Et Al. (2011) . "Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.109, no.2, pp.73-77.

@article{article, author={ÜMİT YAŞAR Et Al. }, title={Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients}, journal={BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY}, year=2011, pages={73-77} }